Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7275 p671
15 November 2003

This article
Reprint
Photocopy


News summary

Related websites
BMJ abstract (more)


Tolerability of malaria prophylaxis

Although generally well tolerated, combined chloroquine and proguanil is associated with more adverse events than other recommended malaria prophylaxis regimens. In a study of 623 non-immune adults travelling to sub-Saharan Africa, chloroquine plus proguanil had the highest proportion of mild to moderate adverse events followed by mefloquine, doxycyline, and the combination of atovaquone and proguanil. The mefloquine and combined chloroquine and proguanil had the highest proportion of more severe events (BMJ 2003;327:1078).

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal